All studies published to date have shown that the use of GnRH agonist for triggering of ovulation prevents the development of ovarian hyperstimulaion syndrome even in patients which are at high risk of developing OHSS. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.